4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001493152-25-018462
10% owner sold 29,515 shares at an average $6.08 ($179,563)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SVF Endurance (Cayman) Ltd · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-15 | Sale : show line 1 in the form 10b5-1 | −16,671 | $6.07 | $101,196 | 15,353,338 | I |
| 2025-10-16 | Sale : show line 2 in the form 10b5-1 | −12,844 | $6.10 | $78,366 | 15,340,494 | I |
| Open-market sales · 29,515 sh · avg $6.08 · $179,563 | ||||||
Loading xslF345X05/ownership.xml…